Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Alcindor

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
JAMA Network Open|March 18, 2021
Cancer and Neurofibromatosis Type 1-Confirming What We Knew and Telling Us Something NewThierry Alcindor
International Journal of Colorectal Disease|March 13, 2008
Activity of paclitaxel in metastatic squamous anal carcinomaThierry Alcindor
Journal of Gastrointestinal Oncology|March 12, 2026
In search of the best perioperative treatment for gastroesophageal cancer: is there a role for antiangiogenesis?Thierry Alcindor
Acta Oncologica (Stockholm, Sweden)|October 28, 2014
Response of refractory Ewing sarcoma to pazopanibThierry Alcindor
JAMA Oncology|April 4, 2024
Immunotherapy in Gastric Cancer-Choosing Methods or ResultsThierry Alcindor
JCO Global Oncology|May 9, 2024
Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?Thierry Alcindor
Journal of Gastrointestinal Oncology|July 20, 2012
Rapid onset of myelodysplastic syndrome after treatment for anal cancer: A case reportThierry Alcindor
Current Treatment Options in Oncology|June 21, 2002
Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphomaThierry Alcindor, Thomas E Witzig
British Journal of Haematology|March 12, 2002
Sideroblastic anaemiasThierry Alcindor, Kenneth R Bridges
Current Oncology (Toronto, Ont.)|February 10, 2021
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case SeriesArielle Elkrief, Suzanne Kazandjian, Thierry Alcindor
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
JAMA Network Open|March 18, 2021
Cancer and Neurofibromatosis Type 1-Confirming What We Knew and Telling Us Something NewThierry Alcindor
International Journal of Colorectal Disease|March 13, 2008
Activity of paclitaxel in metastatic squamous anal carcinomaThierry Alcindor
Journal of Gastrointestinal Oncology|March 12, 2026
In search of the best perioperative treatment for gastroesophageal cancer: is there a role for antiangiogenesis?Thierry Alcindor
Acta Oncologica (Stockholm, Sweden)|October 28, 2014
Response of refractory Ewing sarcoma to pazopanibThierry Alcindor
JAMA Oncology|April 4, 2024
Immunotherapy in Gastric Cancer-Choosing Methods or ResultsThierry Alcindor
JCO Global Oncology|May 9, 2024
Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?Thierry Alcindor
Journal of Gastrointestinal Oncology|July 20, 2012
Rapid onset of myelodysplastic syndrome after treatment for anal cancer: A case reportThierry Alcindor
Current Treatment Options in Oncology|June 21, 2002
Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphomaThierry Alcindor, Thomas E Witzig
British Journal of Haematology|March 12, 2002
Sideroblastic anaemiasThierry Alcindor, Kenneth R Bridges
Current Oncology (Toronto, Ont.)|February 10, 2021
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case SeriesArielle Elkrief, Suzanne Kazandjian, Thierry Alcindor
Pageof 7